Skip to main content

Abstract 24: Differences in Door to Needle and Door In Door Out Times for Tenecteplase vs Alteplase in Acute Ischemic Stroke: Findings From Get With the Guidelines Stroke

Publication ,  Conference
Warach, SJ; Weber, J; Alhanti, B; Messe, S; Schwamm, LH; Fonarow, GC; Sheth, KN; Smith, EE; Mullen, MT; Sampaio Silva, G; Mac Grory, BC ...
Published in: Stroke
February 2024

Tenecteplase (TNK) has arisen as an alternative to alteplase (ALT) for emergent treatment of acute ischemic stroke. Shorter times to prepare and administer TNK raises the possibility that TNK use leads to faster treatment and transfer times. We hypothesized that treatment with TNK is associated with shorter door-to-needle (DTN) and door-in-door-out (DIDO) times. Using the US Get With The Guidelines-Stroke registry, we performed a retrospective, observational cohort study of consecutive patients treated with either TNK or ALT between July 1, 2020 and June 30, 2022. The exposure was treatment with TNK vs ALT. The primary endpoints were DTN and DIDO. We fit generalized linear mixed models to determine the association between TNK (vs ALT) and endpoints after adjustment for key demographic, clinical, and hospital-level variables. A secondary analysis compared changes in DTN among hospitals that switched to TNK in 2021 with at least 10 cases per year pre and post switch. From 2092 sites, 133,228 patients received intravenous thrombolysis. Among the 13,988 (10%) treated with TNK, median age was 70 yrs, median NIHSS 7, 47% female, 21% received endovascular thrombectomy (EVT), and 9% were transferred from the hospital emergency department after receiving lytic. Among 119,240 (90%) treated with ALT, median age was 69 yrs, median NIHSS 7, 48% female; 17% received EVT, and 12% were transferred after lytic. In the primary DTN analysis, time to treatment was shorter with TNK, with mean 47.0 vs 52.7 minutes and DTN ≤60 mins in 77.5% vs 70.7% (TABLE). In the primary DIDO analysis, time to departure was shorter with TNK, 108.3 vs 114.1 minutes. In centers that changed from ALT to TNK during this period DTN times were significantly lower after switching. In this largest study of TNK vs ALT workflow time intervals in ischemic stroke using population-based data, TNK use was associated with more favorable DTN and DIDO times relative to ALT use.

Duke Scholars

Published In

Stroke

DOI

EISSN

1524-4628

ISSN

0039-2499

Publication Date

February 2024

Volume

55

Issue

Suppl_1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Neurology & Neurosurgery
  • 4201 Allied health and rehabilitation science
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Warach, S. J., Weber, J., Alhanti, B., Messe, S., Schwamm, L. H., Fonarow, G. C., … Saver, J. L. (2024). Abstract 24: Differences in Door to Needle and Door In Door Out Times for Tenecteplase vs Alteplase in Acute Ischemic Stroke: Findings From Get With the Guidelines Stroke. In Stroke (Vol. 55). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1161/str.55.suppl_1.24
Warach, Steven J., Jeremy Weber, Brooke Alhanti, Steven Messe, Lee H. Schwamm, Gregg C. Fonarow, Kevin N. Sheth, et al. “Abstract 24: Differences in Door to Needle and Door In Door Out Times for Tenecteplase vs Alteplase in Acute Ischemic Stroke: Findings From Get With the Guidelines Stroke.” In Stroke, Vol. 55. Ovid Technologies (Wolters Kluwer Health), 2024. https://doi.org/10.1161/str.55.suppl_1.24.
Warach SJ, Weber J, Alhanti B, Messe S, Schwamm LH, Fonarow GC, et al. Abstract 24: Differences in Door to Needle and Door In Door Out Times for Tenecteplase vs Alteplase in Acute Ischemic Stroke: Findings From Get With the Guidelines Stroke. In: Stroke. Ovid Technologies (Wolters Kluwer Health); 2024.
Warach, Steven J., et al. “Abstract 24: Differences in Door to Needle and Door In Door Out Times for Tenecteplase vs Alteplase in Acute Ischemic Stroke: Findings From Get With the Guidelines Stroke.” Stroke, vol. 55, no. Suppl_1, Ovid Technologies (Wolters Kluwer Health), 2024. Crossref, doi:10.1161/str.55.suppl_1.24.
Warach SJ, Weber J, Alhanti B, Messe S, Schwamm LH, Fonarow GC, Sheth KN, Smith EE, Mullen MT, Sampaio Silva G, Mac Grory BC, Xian Y, Saver JL. Abstract 24: Differences in Door to Needle and Door In Door Out Times for Tenecteplase vs Alteplase in Acute Ischemic Stroke: Findings From Get With the Guidelines Stroke. Stroke. Ovid Technologies (Wolters Kluwer Health); 2024.

Published In

Stroke

DOI

EISSN

1524-4628

ISSN

0039-2499

Publication Date

February 2024

Volume

55

Issue

Suppl_1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Neurology & Neurosurgery
  • 4201 Allied health and rehabilitation science
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology